NVO - Catalent shareholders approve acquisition by Novo Holdings
2024-05-29 10:18:39 ET
More on Novo Nordisk, Catalent
- Novo Nordisk: The Market Is Right, Don't Fight Against It
- Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study
- Novo Nordisk: Considerable Growth Beyond Ozempic
- SA Asks: Who will launch the next big weight-loss drug?